CFTR expression from a BAC carrying the complete human gene and associated regulatory elements

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 A, 2009, Pages 2938-2948

  Kotzamanis, George ^a,b   Abdulrazzak, Hassan ^b   Gifford Garner, Jennifer ^b   Haussecker, Pei Ling ^c   Cheung, Wing ^b   Grillot Courvalin, Catherine ^d   Harris, Ann ^c,e   Kittas, Christos ^a   Kotsinas, Athanasios ^a   Gorgoulis, Vassilis G ^a   Huxley, Clare ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d INSTITUT PASTEUR   (France)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

BAC; Bacterial invasion; CFTR; Expression; Recombineering

Indexed keywords

MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL LINE; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENE TRANSFER; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; HUMAN; METABOLISM; MOUSE; PULSED FIELD GEL ELECTROPHORESIS; REGULATORY SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; RECOMBINATION, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA;

BACTERIA (MICROORGANISMS);

EID: 72849109552     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00433.x     Document Type: Article

References (55)

1. Grubb BR, Boucher RC. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev. 1999 79 : S193 214.
2. Boucher RC. An overview of the pathogenesis of cystic fibrosis lung disease. Adv Drug Deliv Rev. 2002 54 : 1359 1371.
3. Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 245 : 1059 1065. (Pubitemid 19231813)
4. Crawford I, Maloney PC, Zeitlin PL, et al. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci USA. 1991 88 : 9262 9266.
5. Trezise AE, Chambers JA, Wardle CJ, et al. Expression of the cystic fibrosis gene in human foetal tissues. Hum Mol Genet. 1993 2 : 213 218.
6. Yoshimura K, Nakamura H, Trapnell BC, et al. The cystic fibrosis gene has a "housekeeping"-type promoter and is expressed at low levels in cells of epithelial origin. J Biol Chem. 1991 266 : 9140 9144.
7. Smith AN, Wardle CJ, Harris A. Characterization of DNASE I hypersensitive sites in the 120kb 5′ to the CFTR gene. Biochem Biophys Res Commun. 1995 211 : 274 281.
8. Smith AN, Barth ML, McDowell TL, et al. A regulatory element in intron 1 of the cystic fibrosis transmembrane conductance regulator gene. J Biol Chem. 1996 271 : 9947 9954.
9. Smith DJ, Nuthall HN, Majetti ME, et al. Multiple potential intragenic regulatory elements in the CFTR gene. Genomics. 2000 64 : 90 6.
10. Nuthall HN, Moulin DS, Huxley C, et al. Analysis of DNase-I- hypersensitive sites at the 3′ end of the cystic fibrosis transmembrane conductance regulator gene (CFTR). Biochem J. 1999 341 : 601 611.
11. Nuthall HN, Vassaux G, Huxley C, et al. Analysis of a DNase I hypersensitive site located-20.9 kb upstream of the CFTR gene. Eur J Biochem. 1999 266 : 431 443.
12. Rowntree RK, Vassaux G, McDowell TL, et al. An element in intron 1 of the CFTR gene augments intestinal expression in vivo. Hum Mol Genet. 2001 10 : 1455 1464.
13. Phylactides M, Rowntree R, Nuthall H, et al. Evaluation of potential regulatory elements identified as DNase I hypersensitive sites in the CFTR gene. Eur J Biochem. 2002 269 : 553 559.
14. Moulin DS, Manson AL, Nuthall HN, et al. In vivo analysis of DNase I hypersensitive sites in the human CFTR gene. Mol Med. 1999 5 : 211 223.
15. Vassaux G, Manson AL, Huxley C. Copy number-dependent expression of a YAC-cloned human CFTR gene in a human epithelial cell line. Gene Ther. 1997 4 : 618 623. (Pubitemid 27352960)
16. Manson AL, Trezise AE, MacVinish LJ, et al. Complementation of null CF mice with a human CFTR YAC transgene. EMBO J. 1997 16 : 4238 4249.
17. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 245 : 1066 1073. (Pubitemid 19231814)
18. Dorin JR, Farley R, Webb S, et al. A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther. 1996 3 : 797 801.
19. Alton EW, Middleton PG, Caplen NJ, et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet. 1993 5 : 135 142.
20. Hyde SC, Gill DR, Higgins CF, et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature. 1993 362 : 250 255.
21. Goddard CA, Ratcliff R, Anderson JR, et al. A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea. Gene Ther. 1997 4 : 1231 1236.
22. Limberis M, Anson DS, Fuller M, et al. Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum Gene Ther. 2002 13 : 1961 1970.
23. Rozmahel R, Gyomorey K, Plyte S, et al. Incomplete rescue of cystic fibrosis transmembrane conductance regulator deficient mice by the human CFTR cDNA. Hum Mol Genet. 1997 6 : 1153 1162.
24. Zhou L, Dey CR, Wert SE, et al. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science. 1994 266 : 1705 1708.
25. Caplen NJ, Alton EW, Middleton PG, et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med. 1995 1 : 39 46.
26. Zabner J, Couture LA, Gregory RJ, et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell. 1993 75 : 207 216.
27. Flotte TR, Zeitlin PL, Reynolds TC, et al. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther. 2003 14 : 1079 1088.
28. Moss RB, Rodman D, Spencer LT, et al. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest. 2004 125 : 509 521.
29. Alton EW, Stern M, Farley R, et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet. 1999 353 : 947 954.
30. Konstan MW, Davis PB, Wagener JS, et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther. 2004 15 : 1255 1269.
31. Huertas D, Howe S, McGuigan A, et al. Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells. Hum Mol Genet. 2000 9 : 617 629.
32. Auriche C, Carpani D, Conese M, et al. Functional human CFTR produced by a stable minichromosome. EMBO Rep. 2002 3 : 862 868.
33. Lee EC, Yu D, Martinez de Velasco J, et al. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics. 2001 73 : 56 65.
34. Kotzamanis G, Huxley C. Recombining overlapping BACs into a single larger BAC. BMC Biotechnol. 2004 4 : 1.
35. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Vol. 3. Cold Spring Harbor, New York : Cold Spring Harbor Laboratory 1989.
36. Magin-Lachmann C, Kotzamanis G, D'Aiuto L, et al. Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 - new vectors for in vitro and in vivo delivery. BMC Biotechnol. 2003 3 : 2.
37. Laner A, Goussard S, Ramalho AS, et al. Bacterial transfer of large functional genomic DNA into human cells. Gene Ther. 2005 12 : 1559 1572.
38. Perez-Luz S, Abdulrazzak H, Grillot-Courvalin C, et al. Factor VIII mRNA expression from a BAC carrying the intact locus made by homologous recombination. Genomics. 2007 90 : 610 619.
39. Chalkley G, Harris A. Lymphocyte mRNA as a resource for detection of mutations and polymorphisms in the CF gene. J Med Genet. 1991 28 : 777 780.
40. Jones CT, McIntosh I, Keston M, et al. Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation. Hum Mol Genet. 1992 1 : 11 7.
41. Kotzamanis G, Cheung W, Abdulrazzak H, et al. Construction of human artificial chromosome vectors by recombineering. Gene. 2005 351 : 29 38.
42. Hull J, Shackleton S, Harris A. Analysis of mutations and alternative splicing patterns in the CFTR gene using mRNA derived from nasal epithelial cells. Hum Mol Genet. 1994 3 : 1141 1146.
43. Sopher BL, La Spada AR. Efficient recombination-based methods for bacterial artificial chromosome fusion and mutagenesis. Gene. 2006 371 : 136 143.
44. Zhang XM, Huang JD. Combination of overlapping bacterial artificial chromosomes by a two-step recombinogenic engineering method. Nucleic Acids Res. 2003 31 : 81.
45. Carson S, Wiles MV. Far upstream regions of class II MHC Ea are necessary for position-independent, copy-dependent expression of Ea transgene. Nucleic Acids Res. 1993 21 : 2065 2072.
46. Schedl A, Montoliu L, Kelsey G, et al. A yeast artificial chromosome covering the tyrosinase gene confers copy number-dependent expression in transgenic mice. Nature. 1993 362 : 258 261.
47. Kaufman RM, Pham CT, Ley TJ. Transgenic analysis of a 100-kb human beta-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome. Blood. 1999 94 : 3178 3184.
48. Huang Y, Liu DP, Wu L, et al. Proper developmental control of human globin genes reproduced by transgenic mice containing a 160-kb BAC carrying the human beta-globin locus. Blood Cells Mol Dis. 2000 26 : 598 610.
49. Sarsero JP, Li L, Holloway TP, et al. Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice. Mamm Genome. 2004 15 : 370 382.
50. Slomski R, Schloesser M, Berg LP, et al. Omission of exon 12 in cystic fibrosis transmembrane conductance regulator (CFTR) gene transcripts. Hum Genet. 1992 89 : 615 619.
51. Chu CS, Trapnell BC, Murtagh JJ Jr., et al. Variable deletion of exon 9 coding sequences in cystic fibrosis transm-embrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J. 1991 10 : 1355 1363.
52. Chu CS, Trapnell BC, Curristin S, et al. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet. 1993 3 : 151 156.
53. Cuppens H, Lin W, Jaspers M, et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest. 1998 101 : 487 496.
54. Niksic M, Romano M, Buratti E, et al. Functional analysis of cisacting elements regulating the alternative splicing of human CFTR exon 9. Hum Mol Genet. 1999 8 : 2339 2349.
55. Aznarez I, Chan EM, Zielenski J, et al. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene. Hum Mol Genet. 2003 12 : 2031 2040.